AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $29,000 | -61.3% | 12,680 | -19.6% | 0.00% | – |
Q4 2021 | $75,000 | -39.5% | 15,771 | +0.7% | 0.00% | – |
Q3 2021 | $124,000 | -7.5% | 15,658 | -18.8% | 0.00% | – |
Q2 2021 | $134,000 | -9.5% | 19,293 | +3.2% | 0.00% | – |
Q1 2021 | $148,000 | +8.0% | 18,697 | +7.5% | 0.00% | -100.0% |
Q4 2020 | $137,000 | +57.5% | 17,400 | +41.0% | 0.00% | – |
Q3 2020 | $87,000 | -26.9% | 12,337 | -3.9% | 0.00% | -100.0% |
Q2 2020 | $119,000 | +43.4% | 12,831 | +18.8% | 0.00% | – |
Q3 2019 | $83,000 | +15.3% | 10,801 | +3.3% | 0.00% | – |
Q2 2019 | $72,000 | -21.7% | 10,452 | -8.4% | 0.00% | -100.0% |
Q1 2019 | $92,000 | – | 11,406 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 20,592 | $347,798 | 24.67% |
VR Adviser, LLC | 295,034 | $3,614,167 | 0.38% |
IFP Advisors, Inc | 2,860 | $1,718 | 0.00% |